Published in Brain on October 18, 2013
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. PLoS One (2015) 0.79
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study. PLoS One (2016) 0.78
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset. J Neurol (2015) 0.78
Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up. Mult Scler Int (2014) 0.76
Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis. Neuroimage Clin (2016) 0.75
Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin. Proc Natl Acad Sci U S A (2016) 0.75
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol (2007) 3.87
Familial myelodysplasia and acute myeloid leukaemia--a review. Br J Haematol (2008) 3.74
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52
Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial: short-term results of the Sigma Trial. Ann Surg (2009) 2.89
Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol (2009) 2.87
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A (2008) 2.57
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol (2009) 2.56
Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol (2013) 2.52
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology (2006) 2.43
Emergency department length of stay independently predicts excess inpatient length of stay. Med J Aust (2003) 2.24
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler (2013) 2.20
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis (2013) 2.17
The effect of additional ankle and midfoot mobilizations on plantar fasciitis: a randomized controlled trial. J Orthop Sports Phys Ther (2015) 2.03
Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet (2003) 2.03
Botulinum toxin modulates cortical maladaptation in post-stroke spasticity. Muscle Nerve (2013) 2.00
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study. Mult Scler (2013) 1.99
Substitution Monotherapy With Levetiracetam vs Older Antiepileptic Drugs: A Randomized Comparative Trial. Arch Neurol (2012) 1.99
Fingolimod after natalizumab and the risk of short-term relapse. Neurology (2014) 1.96
The impact of sleep deprivation on product quality and procedure effectiveness in a laparoscopic physical simulator: a randomized controlled trial. Am J Surg (2005) 1.95
Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia (2009) 1.93
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol (2009) 1.88
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain (2012) 1.78
Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ann Neurol (2006) 1.76
Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol (2008) 1.76
Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 1.75
Postinfectious neurologic syndromes: a prospective cohort study. Neurology (2013) 1.73
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet (2010) 1.73
Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology (2004) 1.72
Determinants of recurrence after sigmoid resection for uncomplicated diverticulitis. Dis Colon Rectum (2003) 1.70
Complication rates after Hartmann's reversal: open vs. laparoscopic approach. Dis Colon Rectum (2008) 1.69
Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology (2006) 1.66
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology (2012) 1.62
Ocular and cervical vestibular evoked myogenic potentials in multiple sclerosis patients. Clin Neurophysiol (2012) 1.61
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology (2013) 1.61
Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med (2007) 1.61
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation (2010) 1.60
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis. JAMA Neurol (2015) 1.57
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med (2002) 1.57
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology (2008) 1.55
Serum levels of N-acetyl-aspartate in migraine and tension-type headache. J Headache Pain (2012) 1.54
Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neurosci (2007) 1.53
Split-hand index for the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.52
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One (2009) 1.50
Changes in human sensory axonal excitability induced by an ischaemic insult. Clin Neurophysiol (2008) 1.49
Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med (2005) 1.49
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.49
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One (2010) 1.49
Electrodiagnosis of carpal tunnel syndrome in patients with diabetic polyneuropathy. Clin Neurophysiol (2011) 1.47
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis. Neurology (2013) 1.47
Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler (2011) 1.47
Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis? Neurology (2007) 1.46
Economic impact of primary headaches in Turkey: a university hospital based study: part II. J Headache Pain (2006) 1.45
Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs (2014) 1.44
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry (2009) 1.44
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis. Arq Neuropsiquiatr (2012) 1.43
The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait. PLoS One (2015) 1.43
Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol (2016) 1.42
The N3 potential compared to sound and galvanic vestibular evoked myogenic potential in healthy subjects and in multiple sclerosis patients. J Vestib Res (2007) 1.41
Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy. Clin Neurophysiol (2010) 1.41
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis. Pathology (2012) 1.41
No rectopexy versus rectopexy following rectal mobilization for full-thickness rectal prolapse: a randomized controlled trial. Dis Colon Rectum (2011) 1.41
The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin Ther (2009) 1.40
Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumors. Transfusion (2014) 1.40
Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study. J Surg Oncol (2004) 1.39
Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve. J Hypertens (2014) 1.39
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis. PLoS One (2010) 1.38
[Neuropathy due to elongation of the ilioinguinal nerve]. Rev Neurol (2010) 1.38
Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol (2004) 1.38
Adult acute myeloid leukaemia. Crit Rev Oncol Hematol (2004) 1.37